Srini Pharmaceuticals Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PREGABALIN USP, with a corresponding US DMF Number 24700.
Remarkably, this DMF maintains an Active status since its submission on March 03, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 26, 2018, and payment made on January 04, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II